Abstract
Background: Heart failure with preserved ejection fraction (HFpEF) is linked to cardiometabolic dysregulation and systemic inflammation. The remnant cholesterol inflammatory index (RCII) integrates remnant cholesterol and high-sensitivity C-reactive protein (hs-CRP), but its prognostic relevance in HFpEF is unknown. Methods: This single-center retrospective cohort study included 324 adults hospitalized with HFpEF between March 2022 and May 2026. RCII was calculated as remnant cholesterol (mg/dL) × hs-CRP (mg/L)/10 and log-transformed. The primary endpoint was the first occurrence of all-cause death or HF rehospitalization, termed major adverse cardiovascular events (MACEs) in this study. Associations were assessed by multivariable Cox regression and restricted cubic splines. Incremental value was quantified using net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Results: Over a median follow-up of 24.1 months, 84 patients (25.9%) experienced MACE. Each 1-standard deviation increase in ln(RCII) was associated with the endpoint after adjustment for the measured covariates (adjusted HR, 1.80; 95% CI, 1.38–2.35; p < 0.001), and the highest tertile carried an approximately fourfold higher risk than the lowest (HR, 3.87; 95% CI, 2.02–7.39). The association was graded, without evidence of nonlinearity. Time-dependent AUCs for RCII were 0.655, 0.656, and 0.603 at 12, 24, and 30 months. Adding ln(RCII) raised the C-index of the clinical model from 0.707 to 0.736 (p = 0.040), with improved NRI but no statistically significant IDI improvement. Estimates were similar across 13 exploratory sensitivity analyses, but RCII correlated strongly with hs-CRP (ρ = 0.918) and their prognostic information overlapped substantially. Conclusions: Higher RCII was associated with MACE in HFpEF after adjustment for the measured covariates and provided modest incremental discrimination beyond the clinical model. Superiority over hs-CRP was not demonstrated, and external validation is required.